Jubilant Life Sciences’ wholly owned subsidiary -- Jubilant Biosys has added advanced Pioneer FE system to their platform of drug discovery solutions available to customers. The Pioneer FE system from ForteBio, the Biologics Business Unit of Molecular Devices, represents the next generation SPR instrumentation for label-free characterization of biomolecules.
Sensitive enough to measure high affinity and covalent binding events, the Pioneer systems also uses a unique OneStep gradient injection technology to facilitate fragment screening. Pioneer systems with OneStep technology can analyze up to 768 fragments in 24 hours, obtaining kinetics during the primary screen and eliminating the need for additional screens.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
